CV vs STXS: stock comparison and AI forecast
Capsovision, Inc (CV) and Stereotaxis, Inc. (STXS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CV Capsovision, Inc
- Price
- $6.20 -13.8% · 6M
- Market Cap
- $310M
- P/E Ratio
- 7.4x
- Size
- small-cap
- AI Forecast
STXS Stereotaxis, Inc.
- Market Cap
- $105M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CV is 2.9 times larger than STXS by market capitalization ($310M against $105M).
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CV | STXS |
|---|---|---|
| Market Cap | $310M | $105M |
| P/E Ratio | 7.38x | – |
| P/B Ratio | 23.57x | – |
| EPS | $0.84 | $-0.25 |
| Book Value/Share | $0.26 | – |
| Revenue/Share | $0.33 | $0.30 |
| FCF/Share | $-0.56 | $-0.15 |
Profitability & Margins
| Metric | CV | STXS |
|---|---|---|
| Gross Margin | 51.4% | 55.3% |
| Operating Margin | -213.1% | -75.3% |
| EBT Margin | -211.0% | -75.3% |
| Tax Rate | -0.1% | – |
Financial Health
| Metric | CV | STXS |
|---|---|---|
| Current Ratio | 3.35x | 1.42x |
| Quick Ratio | 2.44x | 0.95x |
| D/E Ratio | 0.41x | – |
| Financial Leverage | 1.41x | – |
| Interest Coverage | -534.6x | -45.7x |
| Working Capital | $12M | $11M |
Cash Flow
| Metric | CV | STXS |
|---|---|---|
| Operating Cash Flow | -$28M | -$15M |
| Free Cash Flow | -$28M | -$16M |
| Capital Spending | -$70K | -$210K |
| FCF/Sales | -167.3% | -51.6% |
| CapEx/Sales | 0.4% | 0.7% |
Operational Efficiency
| Metric | CV | STXS |
|---|---|---|
| Asset Turnover | 0.90x | – |
| Receivables Turnover | 7.4x | 4.0x |
| Inventory Turnover | 1.7x | 1.1x |
| Fixed Assets Turnover | 29.7x | 10.4x |
| Days Sales Outstanding | 50 days | 92 days |
| Days Inventory | 212 days | 342 days |
| Payables Period | 21 days | 188 days |
| Cash Conversion Cycle | 240 days | 246 days |
Income Statement
| Metric | CV | STXS |
|---|---|---|
| Total Revenue | $17M | $30M |
| Operating Income | -$36M | -$23M |
| R&D Expense | $25M | $10M |
| SG&A Expense | $23M | $46M |
| Cost of Goods Sold | $8M | $13M |
Dividend & Shareholder Information
| Metric | CV | STXS |
|---|---|---|
| Shares Outstanding | 50M | 100M |
CV vs STXS: stock comparison and AI forecast
Which is bigger, CV or STXS?
CV is 2.9 times larger than STXS by market capitalization ($310M against $105M).
Which one does Intratio's AI model rank higher, CV or STXS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.